isolate
CD138+ cells from patient ID BOSTON_098 who participated in the BOSTON study and recieved selinexor + bortezomib + dexamethasone
biomaterial_provider
Parekh Lab, Icahn School of Medicine at Mount Sinai
age
63
sex
male
tissue
bone marrow
cell_type
CD138+
disease
multiple myeloma
disease_stage
III
treatment
selinexor + bortezomib + dexamethasone
RIN
8.7
batch
Shipment.002
RNA.Library.Prep.Method
TruSeq Stranded mRNA (non-FFPE compatible)
PFS_Days
115
PFS_Censor
0
Best_Response
PR
BioSampleModel
Human